TEXT-EXTRACT 2 filename2.txt United States securities and exchange commission logo February 26, 2021 Brett Sandercock Chief Financial Officer ResMed Inc. 9001 Spectrum Center Blvd. San Diego, CA 92123 Re: ResMed Inc. Form 10-K for the Fiscal Year Ended June 30, 2020 File No. 001-15317 Filed August 13, 2020 Dear Mr. Sandercock: We have limited our review of your filing to the financial statements and related disclosures and have the following comment. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure. Please respond to this comment within ten business days by providing the requested information or advise us as soon as possible when you will respond. If you do not believe our comment applies to your facts and circumstances, please tell us why in your response. After reviewing your response to this comment, we may have additional comments. Form 10-K for the Fiscal Year Ended June 30, 2020 Item 15 - Exhibits and Consolidated Financial Statement Schedules, page 89 1. We note that there was no consent provided in Exhibit 23.1 as indicated. Please amend to file a consent signed by your independent registered certified public accounting firm. Refer to Item 601(b)(23)(i) of Regulation S-K. In closing, we remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Brett Sandercock ResMed Inc. February 26, 2021 Page 2 You may contact David Burton at (202) 551-3626 or Lynn Dicker, Senior Accountant, at (202) 551-3616 with any questions. FirstName LastNameBrett Sandercock Sincerely, Comapany NameResMed Inc. Division of Corporation Finance February 26, 2021 Page 2 Office of Life Sciences FirstName LastName